Tongeye Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
4
Tongeye General Information
Description
Developer of cell therapy drugs intended for ophthalmic diseases. The company leverages multiple research and development pipelines to transplant unique naive retinal pigment epithelium cells derived from induced pluripotent stem cells to treat dry retinal degeneration with an efficient induction and differentiation method backed by independent intellectual property rights, it has reduced costs, improved accessibility, and accelerated the traditional differentiation cycle, serving clients worldwide to improve vision for patients with dry retinal degeneration.
Contact Information
Website
www.tongeye.comCorporate Office
- Room C201, Number 298 Xueshi Road, Shounan Street
- Yinzhou District
- Ningbo, Zhejiang 315832
- China
Corporate Office
- Room C201, Number 298 Xueshi Road, Shounan Street
- Yinzhou District
- Ningbo, Zhejiang 315832
- China
Tongeye Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 23-Sep-2026 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 30-Jul-2026 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 26-Jun-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 22-Nov-2023 | Completed | Startup |
Tongeye Patents
Tongeye Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026166335-A1 | Use of epo in preparation of drug for preventing and treating corneal injury | Pending | 07-Feb-2025 |
Tongeye Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fuzhi Investment Management | Venture Capital | Minority | ||
| DFJ Fund | Venture Capital | Minority | ||
| Jiashan Xingxiang Investment | Venture Capital | Minority | ||
| V Star Capital | Venture Capital | Minority |
Tongeye FAQs
-
When was Tongeye founded?
Tongeye was founded in 2023.
-
Where is Tongeye headquartered?
Tongeye is headquartered in Ningbo, China.
-
What industry is Tongeye in?
Tongeye’s primary industry is Drug Discovery.
-
Is Tongeye a private or public company?
Tongeye is a Private company.
-
What is Tongeye’s current revenue?
The current revenue for Tongeye is .
-
Who are Tongeye’s investors?
Fuzhi Investment Management, DFJ Fund, Jiashan Xingxiang Investment, and V Star Capital have invested in Tongeye.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process